Journal Information

Most Often Read

41371
WITHDRAWN: Covid-19: Round and oval areas of ground-glass opacity
W. Schmitt, E. Marchiori
41371
Open access
Available online 26 April 2020
39218
New drugs and perspectives for new anti-tuberculosis regimens
S. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
39218
Open access
38444
Diaphragmatic dysfunction
J. Ricoy, N. Rodríguez-Núñez, J.M. Álvarez-Dobaño, M.E. Toubes, V. Riveiro, L. Valdés
Pulmonol. 2019;25:223-35
38444
Open access
26050
COPD exacerbations: management and hospital discharge
A.J. Reis, C. Alves, S. Furtado, J. Ferreira, M. Drummond, C. Robalo-Cordeiro
Pulmonol. 2018;24:345-50
26050
Open access
24187
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis
R. Torres-Castro, L. Vasconcello-Castillo, X. Alsina-Restoy, L. Solis-Navarro, F. Burgos, H. Puppo, J. Vilaró
Pulmonol. 2021;27:328-37
24187
Open access
Open Article
22878
Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age group
R. Marçôa, A.I. Ribeiro, I. Zão, R. Duarte
Pulmonol. 2018;24:199-202
22878
Open access
22497
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
D. Visca, C.W.M. Ong, S. Tiberi, R. Centis, L. D’Ambrosio, B. Chen, J. Mueller, P. Mueller, R. Duarte, M. Dalcolmo, G. Sotgiu, G.B. Migliori, D. Goletti
Pulmonol. 2021;27:151-65
22497
Open access
Open Article
21836
Identification and assessment of COPD exacerbations
A.S. Oliveira, J. Munhá, A. Bugalho, M. Guimarães, G. Reis, A. Marques
Pulmonol. 2018;24:42-7
21836
Open access
21509
Tuberculosis, social determinants and co-morbidities (including HIV)
R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
21509
Open access
Pulmonology

Subscribe to our newsletter

Are you a health professional able to prescribe or dispense drugs?